Total fiscal 2024 revenue increased 12% to $5.5 billionTotal fiscal 2024 U.S. GAAP earnings per diluted share of $3.81; adjusted earnings per diluted share increased to $8.83Targeted restructuring...
DUBLIN, IRELAND, May 01, 2024 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (STERIS or the Company) announced today that the Company will distribute a quarterly interim dividend of $0.52 per...
STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023
ChargePoint and Steris Partner to Provide a Sterile Solution to Evonik
DUBLIN, IRELAND, Oct. 06, 2020 (GLOBE NEWSWIRE) -- STERIS plc (STE) (“STERIS” or the “Company”) today announced that the Company has signed a definitive agreement to purchase Key Surgical, a portfolio company of Water Street Healthcare Partners, LLC, through a U.S. subsidiary for $850 million. STERIS anticipates that the acquisition will qualify for a tax benefit related to tax deductible goodwill. Adjusting for the present value of the anticipated tax benefit, the purchase price is effectively reduced to approximately $810 million. Key Surgical, founded in 1988, is a leading global provider of consumable products serving hospitals and surgical facilities. Annual revenue for Key Surgical in calendar 2020 is anticipated to be approximately $170 million, with adjusted EBIT of approximately $50 million.
Drug price regulator NPPA has fixed retail prices of 14 formulations, including of those used in treatment of high cholesterol and high blood pressure.
Steris Corp recalls 0.75% Triclosan, 444 ml (15 fl oz) bottles